<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IP Patent News &#187; Plan</title>
	<atom:link href="http://www.ip-patent-news.com/tag/plan/feed" rel="self" type="application/rss+xml" />
	<link>http://www.ip-patent-news.com</link>
	<description>24/7 Technology,Internet,Bio Patent and Intellectual Property News &#38; Information Service</description>
	<lastBuildDate>Mon, 06 Sep 2010 04:57:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>MediciGlobal survey identifies strategies followed in patient recruitment for clinical trials</title>
		<link>http://www.news-medical.net/news/20100605/MediciGlobal-survey-identifies-strategies-followed-in-patient-recruitment-for-clinical-trials.aspx</link>
		<comments>http://www.ip-patent-news.com/mediciglobal-survey-identifies-strategies-followed-in-patient-recruitment-for-clinical-trials#comments</comments>
		<pubDate>Sat, 05 Jun 2010 09:56:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Recruitment]]></category>
		<category><![CDATA[Success]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/mediciglobal-survey-identifies-strategies-followed-in-patient-recruitment-for-clinical-trials</guid>
		<description><![CDATA[[Story ID: 2185] Much is written about how patient recruitment can either accelerate or undermine clinical trial success. But how is the industry approaching patient recruitment in general? Do companies plan proactively? Who is involved in the process and what decisions do they make in order to effectively plan for success?]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/mediciglobal-survey-identifies-strategies-followed-in-patient-recruitment-for-clinical-trials">2185</a>]</small>
<p>Much is written about how patient recruitment can either accelerate or undermine clinical trial success. But how is the industry approaching patient recruitment in general? Do companies plan proactively? Who is involved in the process and what decisions do they make in order to effectively plan for success?</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/mediciglobal-survey-identifies-strategies-followed-in-patient-recruitment-for-clinical-trials/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beijing Eases Technology Rule</title>
		<link>http://www.manufacturing.net/News-Beijing-Eases-Technology-Rule-041310.aspx</link>
		<comments>http://www.ip-patent-news.com/beijing-eases-technology-rule#comments</comments>
		<pubDate>Tue, 13 Apr 2010 13:39:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Favor]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/beijing-eases-technology-rule</guid>
		<description><![CDATA[[Story ID: 1277] China has eased requirements for companies to qualify for government purchasing of technology after a plan to favor domestic technology was met with heavy criticism.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/beijing-eases-technology-rule">1277</a>]</small>
<p>China has eased requirements for companies to qualify for government purchasing of technology after a plan to favor domestic technology was met with heavy criticism.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/beijing-eases-technology-rule/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medicare Roundup: Changes from health reform, payments for HIV patients</title>
		<link>http://www.news-medical.net/news/20100326/Medicare-Roundup-Changes-from-health-reform-payments-for-HIV-patients.aspx</link>
		<comments>http://www.ip-patent-news.com/medicare-roundup-changes-from-health-reform-payments-for-hiv-patients#comments</comments>
		<pubDate>Fri, 26 Mar 2010 04:48:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Run]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/medicare-roundup-changes-from-health-reform-payments-for-hiv-patients</guid>
		<description><![CDATA[[Story ID: 1010] USA Today: &#8220;Perhaps the biggest factor in whether your Medicare costs will rise or fall depends on your Medicare plan. There are two: a traditional Medicare plan run by the federal government and Medicare Advantage, which is run by private insurance companies. Medicare Advantage costs more than the traditional plan, but provides [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/medicare-roundup-changes-from-health-reform-payments-for-hiv-patients">1010</a>]</small>
<p>USA Today: &#8220;Perhaps the biggest factor in whether your Medicare costs will rise or fall depends on your Medicare plan. There are two: a traditional Medicare plan run by the federal government and Medicare Advantage, which is run by private insurance companies. Medicare Advantage costs more than the traditional plan, but provides more generous benefits.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/medicare-roundup-changes-from-health-reform-payments-for-hiv-patients/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study shows value-based plans can improve adherence for diabetes medicines</title>
		<link>http://www.news-medical.net/news/20100217/Study-shows-value-based-plans-can-improve-adherence-for-diabetes-medicines.aspx</link>
		<comments>http://www.ip-patent-news.com/study-shows-value-based-plans-can-improve-adherence-for-diabetes-medicines#comments</comments>
		<pubDate>Wed, 17 Feb 2010 06:01:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Cvs]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Participants]]></category>
		<category><![CDATA[Plan]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/study-shows-value-based-plans-can-improve-adherence-for-diabetes-medicines</guid>
		<description><![CDATA[[Story ID: 391] A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/study-shows-value-based-plans-can-improve-adherence-for-diabetes-medicines">391</a>]</small>
<p>A study by CVS Caremark (NYSE: CVS), published this week in the American Journal of Pharmacy Benefits, finds that insurance benefit designs that reduce the cost of medications for plan participants result in patients being more likely to start and stay on their medication therapy.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/study-shows-value-based-plans-can-improve-adherence-for-diabetes-medicines/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pioneer(R) Surgical Technology, Inc. Announces New Expansion Plan (redOrbit)</title>
		<link>http://www.redorbit.com/news/health/1816040/pioneerr_surgical_technology_inc_announces_new_expansion_plan/index.html?source=r_health</link>
		<comments>http://www.ip-patent-news.com/pioneerr-surgical-technology-inc-announces-new-expansion-plan-redorbit#comments</comments>
		<pubDate>Fri, 29 Jan 2010 20:09:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Companys]]></category>
		<category><![CDATA[Open]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/?p=100</guid>
		<description><![CDATA[[Story ID: 100] MARQUETTE, Mich., Jan. 29 /PRNewswire/ &#8212; Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company&#8217;s plan to open a new office facility in Austin, Texas, April 1, 2010.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/pioneerr-surgical-technology-inc-announces-new-expansion-plan-redorbit">100</a>]</small>
<p>MARQUETTE, Mich., Jan. 29 /PRNewswire/ &#8212; Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company&#8217;s plan to open a new office facility in Austin, Texas, April 1, 2010.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/pioneerr-surgical-technology-inc-announces-new-expansion-plan-redorbit/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transitioning to Beta Site</title>
		<link>http://www.patentbytes.com/component/content/article/15-patentbytes-news/3-transitioning-to-beta-site</link>
		<comments>http://www.ip-patent-news.com/transitioning-to-beta-site#comments</comments>
		<pubDate>Sun, 08 Jun 2008 04:17:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Patent Bytes]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Running]]></category>
		<category><![CDATA[Site]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/?p=72</guid>
		<description><![CDATA[[Story ID: 72] Beginning today, www.patentbytes.com will take you to the new beta site. The old site is still up and running, and I&#8217;ve provided a link at the bottom of the page to the old site. The old site will continue to be updated and maintained just as it always has for the foreseeable [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/transitioning-to-beta-site">72</a>]</small>
<p>Beginning today, www.patentbytes.com will take you to the new beta site.  The old site is still up and running, and I&#8217;ve provided a link at the bottom of the page to the old site.  The old site will continue to be updated and maintained just as it always has for the foreseeable future.  My plan is to keep both sites running in parallel until I reach a point where I&#8217;m confident that the new site is stable and offers the same features as the old site.  Well, at least those features that I plan to keep.   If you would like to link directly to the old site, you can do so by using the url www.patentbytes.com/index.php.  </p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/transitioning-to-beta-site/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PatentBytes 2.0 Beta</title>
		<link>http://www.patentbytes.com/component/content/article/15-patentbytes-news/2-patentbytes-20-beta</link>
		<comments>http://www.ip-patent-news.com/patentbytes-2-0-beta#comments</comments>
		<pubDate>Fri, 06 Jun 2008 03:06:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Continue]]></category>
		<category><![CDATA[Patent Bytes]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Site]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/?p=71</guid>
		<description><![CDATA[[Story ID: 71] Welcome to the Beta site for the new PatentBytes website! This site is still under construction and undergoing testing. I plan to continue to add many of the same features that were included on the old PB site. The new PB site will still provide the latest IP-related headlines and blog titles [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/patentbytes-2-0-beta">71</a>]</small>
<p class="caption">Welcome to the Beta site for the new PatentBytes website!</p>
<p class="caption">This site is still under construction and undergoing testing.  I plan to continue to add many of the same features that were included on the old PB site.  The new PB site will still provide the latest IP-related headlines and blog titles from around the web.   I also plan to continue blogging about IP issues as things capture my interest and as time permits.  I&#8217;m not a professional or paid blogger &#8211; this is nothing more than a hobby for me.  I&#8217;ve got a few other ideas I&#8217;m kicking around in my head.  My main goal for the new site is to make information more visible and easier to find.  I hope it becomes a useful resource for you.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/patentbytes-2-0-beta/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
